A, E., L, S., B, Y., W, G., & Q, X. (2021). Selective targeting of the androgen receptor-DNA binding domain by the novel antiandrogen SBF-1 and inhibition of the growth of prostate cancer cells. Investigational new drugs, 39(2), 442. https://doi.org/10.1007/s10637-020-01050-w
Chicago Style (17th ed.) CitationA, Elgehama, Sun L, Yu B, Guo W, and Xu Q. "Selective Targeting of the Androgen Receptor-DNA Binding Domain by the Novel Antiandrogen SBF-1 and Inhibition of the Growth of Prostate Cancer Cells." Investigational New Drugs 39, no. 2 (2021): 442. https://doi.org/10.1007/s10637-020-01050-w.
MLA (9th ed.) CitationA, Elgehama, et al. "Selective Targeting of the Androgen Receptor-DNA Binding Domain by the Novel Antiandrogen SBF-1 and Inhibition of the Growth of Prostate Cancer Cells." Investigational New Drugs, vol. 39, no. 2, 2021, p. 442, https://doi.org/10.1007/s10637-020-01050-w.